Abstract
Searching for bioactive compounds within the huge chemical space is like trying to find a needle in a haystack. Isatin is a unique natural compound which is endowed with different bio-pertinent activities, especially in cancer therapy. Herein, we envisaged that adopting a hybrid strategy of isatin and α,β-unsaturated ketone would afford new chemical entities with strong chemotherapeutic potential. Of interest, compounds 5b and 5g demonstrated significant antiproliferative activities against different cancer genotypes according to NCI-60 screening. Concomitantly, their IC50 against HL-60 cells were 0.38 ± 0.08 and 0.57 ± 0.05 µM, respectively, demonstrating remarkable apoptosis and moderate cell cycle arrest at G1 phase. Intriguingly, an impressive safety profile for 5b was reflected by a 37.2 times selectivity against HL-60 over PBMC from a healthy donor. This provoked us to further explore their mechanism of action by in vitro and in silico tools. Conclusively, 5b and 5g stand out as strong chemotherapeutic agents that hold clinical promise against acute myeloid leukemia.
Funder
Japan Society for the Promotion of Science
Egypt-Japan Education Partnership
Japan International Cooperation Agency
Egyptian Ministry of High Education (MOHE)-Cultural Affairs and Missions Sector
Umm Al-Qura University with grant code
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference56 articles.
1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int. J. Cancer,2015
2. Design, synthesis and QSAR study of novel isatin analogues inspired Michael acceptor as potential anticancer compounds;Wang;Eur. J. Med. Chem.,2018
3. (2022, November 15). Key Statistics for Acute Myeloid Leukemia (AML), (n.d.). Available online: https://www.cancer.org/cancer/acute-myeloid-leukemia/about/key-statistics.html.
4. Clinical characteristics and outcome of childhood de novo acute myeloid leukemia in Saudi Arabia: A multicenter SAPHOS leukemia group study;Jastaniah;Leuk. Res. C,2016
5. (2022, November 15). What Is Acute Myeloid Leukemia (AML)?|What Is AML? (n.d.). Available online: https://www.cancer.org/cancer/acute-myeloid-leukemia/about/what-is-aml.html.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献